BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Drug Information Association to Host Annual Canadian Meeting: New Realities/New Frontiers


10/23/2013 12:07:29 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OTTAWA—DIA will host the Annual Canadian Meeting: New Realities/New Frontiers from Oct. 29 to 30 at the Ottawa Marriott Hotel, bringing together worldwide leaders in regulation, industry, research and patient advocacy to discuss how the progress being made in patient-centered care can be translated into change in the drug development pipeline and regulatory processes.

Sessions will be devoted to the challenges faced by industry and regulators, the impact of global collaboration, and the need to provide patients and clinical professionals with increased access to drug information.

“New advancements such as novel products and technologies and personalized medicine models and cell therapies call for innovations in Canada’s regulatory landscape to maximize benefit to the patient,” said Barbara Lopez Kunz, global chief executive of DIA. “The meeting will explore how patients, health care professionals, industry and regulators can embrace these changes while placing patient safety and greater access to drugs at the forefront of their work.”

Kathryn McDade, assistant deputy minister of Health Canada’s Health Products and Food Branch, will deliver the opening remarks, followed by the plenary debate, “International Regulatory Cooperation: Trends and Impacts.” The session will focus on the impact of international cooperation on public policy and drug regulation, and highlight key initiatives that encourage interagency collaboration.

The Annual Canadian Meeting sessions include:

- Stakeholder Perspective, Oct. 29, 11 a.m.: As the industry seeks to bring products to global markets with a unified approach to research and development, companies face national laws and diversified regulatory requirements. The session will provide insight into the involvement of stakeholders in the regulatory harmonization process. Chanez-Narimene Kebache, manager of pharmacovigilance in Canada for Mallinckrodt Pharmaceuticals, will lead the session with key representatives from Health Canada and AstraZeneca, as well as patient advocates.

- IT Modernization, Oct. 30, 8:30 a.m.: Chaired by Paul Litowitz, associate director of the Bureau of Metabolism, Oncology and Reproductive Sciences, Therapeutic Products Directorate, Health Canada, the session will present the overall features of information technology modernization in the areas of website, e-signature and other electronic gateway platforms for market authorization and clinical trials.

- It’s BIG and It’s Coming, Oct. 30, 1 p.m.: Presented by Karen Feltmate, president of Redstone Health Group Inc., and representatives of Health Canada’s Therapeutic Products Directorate, the session will address significant imminent changes for the industry and regulators alike, focusing on topics such as strategic risk management, class-action lawsuits and patient home care.

To find out more about the event and to register, visit DIA’s Annual Canadian Meeting website.

ABOUT DIA: DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C.; and Latin America. Visit our website at www.diahome.org and follow DIA at: LinkedIn, Twitter, YouTube, Facebook, Flickr and Pinterest.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES